Product Details
Carboplatine Viatris (10 mg/mL, 450 mg/45 mL) In Pakistan
Carboplatine Viatris 10 mg/mL (450 mg/45 mL) is an intravenous chemotherapy medicine containing carboplatin, a platinum-based anticancer agent. It works by damaging the DNA of rapidly dividing cells, helping to stop or slow the growth of cancer cells. Carboplatin 10 mg/mL preparations are used in chemotherapy regimens for cancers including ovarian carcinoma and, depending on the treatment protocol, small-cell lung carcinoma.
Benefits
- Used as part of chemotherapy treatment for certain cancers.
- May be used in the treatment of ovarian cancer.
- Can be included in combination chemotherapy regimens with other anticancer medicines.
- Works by interfering with cancer-cell DNA and cell division.
- The 450 mg/45 mL presentation provides a concentrated solution intended for controlled intravenous administration.
Specifications
- Brand: Carboplatine Viatris
- Active Ingredient: Carboplatin
- Strength: 10 mg/mL
- Total Strength: 450 mg
- Volume: 45 mL
- Dosage Form: Concentrate/Solution for IV infusion
- Route: Intravenous infusion
- Drug Class: Platinum-based antineoplastic agent
- Prescription Status: Prescription-only medicine
- Storage: Storage requirements depend on the specific manufacturer's formulation; follow the product packaging and pharmacy/oncology department instructions.
How To Use
Carboplatine Viatris must only be prepared and administered by qualified healthcare professionals experienced in cancer chemotherapy. It is given slowly into a vein, generally as an intravenous infusion lasting 15 minutes or longer. The exact dose and treatment schedule are determined by the oncologist based on factors such as the type of cancer, treatment regimen, blood counts and kidney function.
Do not self-administer or use this medicine without specialist medical supervision. Blood counts and kidney function should be monitored during treatment because carboplatin can cause significant bone-marrow suppression.
Why Choose Carboplatine Viatris?
Carboplatin is an established platinum-based chemotherapy medicine used in oncology treatment protocols. The 10 mg/mL, 450 mg/45 mL presentation provides a standardized concentration for professional preparation and intravenous administration when prescribed as part of an appropriate chemotherapy regimen.
